Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

Korea's Hanmi Pharmaceutical to launch first homegrown GLP-1 drug Eppe by year-end, potentially undercutting Wegovy and Mounjaro with estimated ₩150,000 ($111) per four-week supply.

05/10/2026 02:23 UTC
Share
Complaint Report
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
i
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.